A phase I study of TAK-659 and paclitaxel in patients with taxane-refractory advanced solid tumors.
Gouda MA, Shunyakova J, Naing A, Dumbrava E, Hong DS, Yuan Y, Yang P, Myers A, Liang Y, Peng J, Karp D, Tsimberidou AM, Rodon J, Yap TA, Piha-Paul SA, Meric-Bernstam F, Fu S.
Gouda MA, et al. Among authors: yang p.
ESMO Open. 2024 Jun;9(6):103486. doi: 10.1016/j.esmoop.2024.103486. Epub 2024 Jun 8.
ESMO Open. 2024.
PMID: 38914452
Free article.
Clinical Trial.